Navigation Links
Pharmaceutical Companies On Defense As Post-ACA Implementation Continues
Date:4/22/2013

NASHVILLE, Tenn., April 22, 2013 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, studies the collaboration that exists among payers, providers and Accountable Care Organizations (ACOs) across the United States. This web of interconnectedness—which encompasses physicians, physician groups, hospitals, health systems, ACOs, health plan companies, and Managed Care Organizations (MCOs)—varies greatly from market to market. Pharmaceutical companies with granular understanding of these affiliations are better able to scope and target brand opportunities, allocate resources and create meaningful partnerships.

"Now more than ever, it is critical for pharma to know its markets--how decision-makers are aligned and who is changing the face of the local landscape via ACO formation. This is the essence of being a value partner," explains Laura Beerman , Product Manager at HealthLeaders-InterStudy, "specific, actionable knowledge will be vital—especially in situations that require quick decision-making on the move, like prepping for an account call while on the road."

Save the Dates for Our Upcoming Online Open Training!
HealthCare Network Manager: Leverage the Affiliations
June 6, July 11, August 15, September 26  |  2pm Eastern  |  11am Pacific 
HealthLeaders-InterStudy offers Open Training to pharmaceutical company executives that want to find out more about the relationships payers, providers and ACOs share.  For more information about Open Training and to register, please click here or visit our website here.

About HealthCare Network ManagerHealthCare Network Manager is a unique, user-friendly tool that links payer and provider relationships with data sets nationally. It is the first—and only—database of its kind.  In one comprehensive solution, pharmaceutical executives can easily identify the interconnectedness of a particular market, allowing them to save time and make smart decisions. HealthCare Network Manager has a NEW mobile-friendly interface and dynamic search capabilities.

About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources Group company, is the authoritative source for managed care data, analysis, and news. HealthLeaders-InterStudy is part of the Market Access Business Unit at Decision Resources Group which also includes Abacus International, Fingertip Formulary, Pinsonault, and PharmaStrat. Find out more at www.hl-isy.com.

About Decision Resources GroupDecision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Lydia Smith

Elizabeth MarshallHealthLeaders-InterStudy

Decision Resources Group 781-993-2594

781-993-2563 lsmith@dresources.com

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
2. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisition Of Obagi Medical Products, Inc.
3. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
4. Biopharmaceutical Managed Care Strength Closely Intertwined with Marketplace Success
5. ADial Pharmaceuticals Announces Agreement With FDA For Phase III Trial Of AD04 For Alcohol Use Disorder In Patients Of Targeted Genotypes
6. Comparison of Biopharmaceutical Industry Between China and India 2013
7. Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
8. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
9. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
10. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
11. Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/28/2016)...   Click here for supplemental information regarding ... the nation,s largest independent specialty pharmacy, announced today ... acquire Valley Campus Pharmacy, Inc., doing business as ... pharmacy that provides individualized patient care, based in ... 2015, TNH generated approximately $400 million in revenue. ...
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
Breaking Medicine Technology:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... engineer of patented products, announces the Gyrociser, an exercise invention which aids in ... $2 billion," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... ... City based oral and maxillofacial surgeon Dr. Majid Jamali is an expert in ... apnea. Dr. Jamali is proud to offer this permanent solution to patients who suffer from ... bones. This surgery is performed to correct the alignment of the jaw. It is beneficial ...
(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip meals occasionally ... miss. That was among the many new lifestyle diet tips offered by nutritionists Pam ... Hour® Power of Water® radio show. Bonny and Lawrence noted that because proper nutrition, ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery Channel. ... cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product research ...
Breaking Medicine News(10 mins):